Early Acne Improvements With Fixed-Combination Topical Therapy: Analysis of the First 4 Weeks of Treatment
In clinical trials of topical fixed-combination formulations, triple-combination CLIN 1.2%/ADAP 0.15%/BPO 3.1% gel yielded greater lesion reductions and rates of treatment success after 4 weeks of treatment than dyad combinations. Even greater differences may be expected with real-world world use, as early improvements may bolster treatment adherence and long-term outcomes. J Drugs Dermatol. 2025;24(1):79-87. doi:10.36849/JDD.8712.
Authors
- Steven R. Feldman (ORCID: https://orcid.org/0000-0002-0090-6289)
- Katie Lovell (ORCID: https://orcid.org/0009-0005-0098-8455)
- Eric Guenin
- Emil Tanghetti (ORCID: https://orcid.org/0000-0002-1115-3219)
- Edward Lain (ORCID: https://orcid.org/0000-0002-3805-9441)
- Linda Stein Gold (ORCID: https://orcid.org/0000-0002-2758-1605)
- Julie Harper (ORCID: https://orcid.org/0000-0001-7181-8721)
- Leon Kircik (ORCID: https://orcid.org/0000-0002-0831-2151)
- Hilary E. Baldwin (ORCID: https://orcid.org/0009-0002-3540-3670)
- Robin C. Yi
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.36849/jdd.8712
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00